Annual Net Income
-$104.70 M
-$3.63 M-3.59%
December 31, 2023
Summary
- As of February 7, 2025, STOK annual net profit is -$104.70 million, with the most recent change of -$3.63 million (-3.59%) on December 31, 2023.
- During the last 3 years, STOK annual net income has fallen by -$52.46 million (-100.41%).
- STOK annual net income is now -1783.75% below its all-time high of -$5.56 million, reached on December 31, 2017.
Performance
STOK Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$26.43 M
-$735.00 K-2.86%
September 30, 2024
Summary
- As of February 7, 2025, STOK quarterly net profit is -$26.43 million, with the most recent change of -$735.00 thousand (-2.86%) on September 30, 2024.
- Over the past year, STOK quarterly net income has dropped by -$1.89 million (-7.69%).
- STOK quarterly net income is now -1282.32% below its all-time high of -$1.91 million, reached on March 31, 2018.
Performance
STOK Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$105.46 M
-$1.89 M-1.82%
September 30, 2024
Summary
- As of February 7, 2025, STOK TTM net profit is -$105.46 million, with the most recent change of -$1.89 million (-1.82%) on September 30, 2024.
- Over the past year, STOK TTM net income has dropped by -$2.06 million (-1.99%).
- STOK TTM net income is now -5415.53% below its all-time high of -$1.91 million, reached on March 31, 2018.
Performance
STOK TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
STOK Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -3.6% | -7.7% | -2.0% |
| 3 y3 years | -100.4% | -7.7% | -2.0% |
| 5 y5 years | -736.2% | -7.7% | -2.0% |
STOK Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -22.0% | at low | -17.2% | +13.8% | -22.9% | +2.8% |
| 5 y | 5-year | -223.9% | at low | -160.1% | +13.8% | -226.2% | +2.8% |
| alltime | all time | -1783.8% | at low | -1282.3% | +13.8% | -5415.5% | +2.8% |
Stoke Therapeutics Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$26.43 M(+2.9%) | -$105.46 M(+1.8%) |
| Jun 2024 | - | -$25.70 M(-2.6%) | -$103.57 M(-4.6%) |
| Mar 2024 | - | -$26.37 M(-2.2%) | -$108.53 M(+3.7%) |
| Dec 2023 | -$104.70 M(+3.6%) | -$26.96 M(+9.8%) | -$104.70 M(+1.3%) |
| Sep 2023 | - | -$24.54 M(-19.9%) | -$103.40 M(-1.5%) |
| Jun 2023 | - | -$30.65 M(+36.0%) | -$104.97 M(+6.1%) |
| Mar 2023 | - | -$22.55 M(-12.1%) | -$98.96 M(-2.1%) |
| Dec 2022 | -$101.07 M(+17.8%) | -$25.66 M(-1.7%) | -$101.07 M(+1.2%) |
| Sep 2022 | - | -$26.11 M(+5.9%) | -$99.86 M(+3.6%) |
| Jun 2022 | - | -$24.65 M(+0.0%) | -$96.35 M(+2.9%) |
| Mar 2022 | - | -$24.65 M(+0.8%) | -$93.66 M(+9.2%) |
| Dec 2021 | -$85.81 M | -$24.45 M(+8.2%) | -$85.81 M(+13.0%) |
| Sep 2021 | - | -$22.60 M(+2.9%) | -$75.92 M(+13.3%) |
| Jun 2021 | - | -$21.97 M(+30.8%) | -$67.00 M(+15.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | -$16.79 M(+15.3%) | -$58.00 M(+11.0%) |
| Dec 2020 | -$52.24 M(+61.6%) | -$14.56 M(+6.4%) | -$52.24 M(+9.2%) |
| Sep 2020 | - | -$13.68 M(+5.6%) | -$47.84 M(+11.9%) |
| Jun 2020 | - | -$12.96 M(+17.4%) | -$42.76 M(+13.7%) |
| Mar 2020 | - | -$11.04 M(+8.7%) | -$37.62 M(+16.4%) |
| Dec 2019 | -$32.33 M(+158.2%) | -$10.16 M(+18.1%) | -$32.33 M(+22.2%) |
| Sep 2019 | - | -$8.60 M(+10.0%) | -$26.45 M(+25.0%) |
| Jun 2019 | - | -$7.82 M(+36.2%) | -$21.16 M(+29.4%) |
| Mar 2019 | - | -$5.74 M(+34.1%) | -$16.35 M(+30.6%) |
| Dec 2018 | -$12.52 M(+125.3%) | -$4.28 M(+29.1%) | -$12.52 M(+52.0%) |
| Sep 2018 | - | -$3.32 M(+10.2%) | -$8.24 M(+67.4%) |
| Jun 2018 | - | -$3.01 M(+57.4%) | -$4.92 M(+157.4%) |
| Mar 2018 | - | -$1.91 M | -$1.91 M |
| Dec 2017 | -$5.56 M | - | - |
FAQ
- What is Stoke Therapeutics annual net profit?
- What is the all time high annual net income for Stoke Therapeutics?
- What is Stoke Therapeutics annual net income year-on-year change?
- What is Stoke Therapeutics quarterly net profit?
- What is the all time high quarterly net income for Stoke Therapeutics?
- What is Stoke Therapeutics quarterly net income year-on-year change?
- What is Stoke Therapeutics TTM net profit?
- What is the all time high TTM net income for Stoke Therapeutics?
- What is Stoke Therapeutics TTM net income year-on-year change?
What is Stoke Therapeutics annual net profit?
The current annual net income of STOK is -$104.70 M
What is the all time high annual net income for Stoke Therapeutics?
Stoke Therapeutics all-time high annual net profit is -$5.56 M
What is Stoke Therapeutics annual net income year-on-year change?
Over the past year, STOK annual net profit has changed by -$3.63 M (-3.59%)
What is Stoke Therapeutics quarterly net profit?
The current quarterly net income of STOK is -$26.43 M
What is the all time high quarterly net income for Stoke Therapeutics?
Stoke Therapeutics all-time high quarterly net profit is -$1.91 M
What is Stoke Therapeutics quarterly net income year-on-year change?
Over the past year, STOK quarterly net profit has changed by -$1.89 M (-7.69%)
What is Stoke Therapeutics TTM net profit?
The current TTM net income of STOK is -$105.46 M
What is the all time high TTM net income for Stoke Therapeutics?
Stoke Therapeutics all-time high TTM net profit is -$1.91 M
What is Stoke Therapeutics TTM net income year-on-year change?
Over the past year, STOK TTM net profit has changed by -$2.06 M (-1.99%)